Affirm Prone Biopsy System
Payments companies reported to CMS as associated with Affirm Prone Biopsy System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Affirm Prone Biopsy System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Affirm Prone Biopsy System
These are the largest totals companies reported as associated with Affirm Prone Biopsy System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Krystal Airola | Stony Brook, NY | Diagnostic Radiology | $3,658.85 |
| Valerie Gorman | Waxahachie, TX | Surgery | $1,800.00 |
| Michael Morris | Scottsdale, AZ | Diagnostic Radiology | $800.00 |
| Ryan Gabriel | North Chesterfield, VA | Diagnostic Radiology | $350.00 |
| Wendie Berg | Owings Mills, MD | Diagnostic Radiology | $350.00 |
| Genevieve Woodard | Chapel Hill, NC | Diagnostic Radiology | $154.15 |
| James Schlund | Chico, CA | Diagnostic Radiology | $154.15 |
| Timothy Rooney | Charlottesville, VA | Diagnostic Radiology | $154.15 |
| Amy Patel | Saint Louis, MO | Diagnostic Radiology | $154.14 |
| Asha Bhatt | Tampa, FL | Diagnostic Radiology | $154.14 |
Prescribed Affirm Prone Biopsy System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.